Skip to main content

Table 1 Baseline characteristics

From: Changes in microparticle profiles by vitamin D receptor activation in chronic kidney disease – a randomized trial

  1. BMI Body mass index, CKD Chronic kidney disease, CVD Cardiovascular disease, TIA Transient ischaemic attack, ACE-i Angiotensin converting enzyme inhibitor, ARB Angiotensin receptor blocker, Ca flow-inh Calcium flow inhibitor. Values are expressed as mean (SD)